title: A multi-scale model of hepcidin promoter regulation reveals factors controlling systemic iron homeostasis.
abstract: Systemic iron homeostasis involves a negative feedback circuit in which the expression level of the peptide hormone hepcidin depends on and controls the iron blood levels. Hepcidin expression is regulated by the BMP6/SMAD and IL6/STAT signaling cascades. Deregulation of either pathway causes iron-related diseases such as hemochromatosis or anemia of inflammation. We quantitatively analyzed how BMP6 and IL6 control hepcidin expression. Transcription factor (TF) phosphorylation and reporter gene expression were measured under co-stimulation conditions, and the promoter was perturbed by mutagenesis. Using mathematical modeling, we systematically analyzed potential mechanisms of cooperative and competitive promoter regulation by the transcription factors, and experimentally validated the model predictions. Our results reveal that hepcidin cross-regulation primarily occurs by combinatorial transcription factor binding to the promoter, whereas signaling crosstalk is insignificant. We find that the presence of two BMP-responsive elements enhances the steepness of the promoter response towards the iron-sensing BMP signaling axis, which promotes iron homeostasis in vivo. IL6 co-stimulation reduces the promoter sensitivity towards the BMP signal, because the SMAD and STAT transcription factors compete for recruiting RNA polymerase to the transcription start site. This may explain why inflammatory signals disturb iron homeostasis in anemia of inflammation. Taken together, our results reveal why the iron homeostasis circuit is sensitive to perturbations implicated in disease.
authors.affiliation: Department of Pediatric Oncology, Hematology and Immunology, University Hospital of Heidelberg, Heidelberg, Germany ; Molecular Medicine Partnership Unit, Heidelberg, Germany ; European Molecular Biology Laboratory, Heidelberg, Germany.
authors.forename: Guillem
authors.initials: G
authors.lastname: Casanovas
authors.affiliation: Institute of Molecular Biology (IMB), Mainz, Germany ; BioQuant, Heidelberg, Germany.
authors.forename: Anashua
authors.initials: A
authors.lastname: Banerji
authors.affiliation: Department of Pediatric Oncology, Hematology and Immunology, University Hospital of Heidelberg, Heidelberg, Germany ; Molecular Medicine Partnership Unit, Heidelberg, Germany ; European Molecular Biology Laboratory, Heidelberg, Germany.
authors.forename: Flavia
authors.initials: F
authors.lastname: d'Alessio
authors.affiliation: Department of Pediatric Oncology, Hematology and Immunology, University Hospital of Heidelberg, Heidelberg, Germany ; Molecular Medicine Partnership Unit, Heidelberg, Germany ; European Molecular Biology Laboratory, Heidelberg, Germany.
authors.forename: Martina U
authors.initials: MU
authors.lastname: Muckenthaler
authors.affiliation: Institute of Molecular Biology (IMB), Mainz, Germany ; BioQuant, Heidelberg, Germany.
authors.forename: Stefan
authors.initials: S
authors.lastname: Legewie
mesh_terms: D000465:Algorithms; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D045744:Cell Line, Tumor; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D017930:Genes, Reporter; D064451:Hepcidins / Q000235:genetics*; D006706:Homeostasis; D006801:Humans; D007249:Inflammation; D015850:Interleukin-6 / Q000378:metabolism; D007501:Iron / Q000378:metabolism*; D008962:Models, Theoretical; D016296:Mutagenesis; D010455:Peptides / Q000737:chemistry; D010766:Phosphorylation; D011401:Promoter Regions, Genetic; D015398:Signal Transduction; D013816:Thermodynamics; D014157:Transcription Factors / Q000378:metabolism
chemical_list: D019485:Bone Morphogenetic Proteins; D064451:Hepcidins; D015850:Interleukin-6; D010455:Peptides; D014157:Transcription Factors; D007501:Iron